News Agency
The Times

Samsung Biologics launches high-concentration formulation platform to accelerate high-dose drug development

  • Written by PR Newswire
Samsung Biologics launches high-concentration formulation platform to accelerate high-dose drug development
  • S-HiConTM is designed to maximize drug delivery and stability through high-concentration formulation
  • The platform can address challenges associated with viscosity and achieve stable liquid formulation for over 200 mg/mL subcutaneous administration

INCHEON, South Korea, Oct. 14, 2024 /PRNewswire/ -- Samsung Biologics (KRX: 207940.KS), a global...

Read more: Samsung Biologics launches high-concentration formulation platform to accelerate high-dose drug...

How Can Businesses Reduce the Risk of Commercial Litigation?

Commercial disputes often begin with a misunderstanding, an unclear contract or a delayed response to a growing problem. Seeking early advice from Litigation Lawyers Sydney with PCL lawyers can help businesses trust and identify legal risks, clarify obligations and create a strategy... Read more

Writers Wanted



NewsServices.com

Content & Technology Connecting Global Audiences

More Information - Less Opinion